Search for: "United States v. Article of Drug" Results 221 - 240 of 2,453
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Aug 2015, 10:56 am
Forest Laboratories, a case from the Lexapro MDL, the court agreed with defendant’s argument that per Bartlett, the United States Supreme Court has held that design defect claims involving pharmaceutical products are preempted. [read post]
24 Jun 2013, 6:08 am by Bradley Graveline
On June 17, 2013, the United States Supreme Court announced a rule that blurs the lines between antitrust and patent law in the context of Hatch-Waxman litigation. [read post]
11 Jan 2009, 7:42 am
The questions before the court are whether the random drug testing policy adopted by the Board as a state actor violates the Fourth Amendment to the United States Constitution, Article III, § 6 of the West Virginia Constitution, and the right to privacy as it is recognized in this state. [read post]
25 Sep 2015, 11:15 am by Native American Rights Fund
Jewell (Attorney Fees, Trust Fund) United States Federal Trial Courts Bulletin http://www.narf.org/nill/bulletins/dct/2015dct.htmlSisseton Wahpeton Oyate of the Lake Traverse Reservation v. [read post]
2 Dec 2023, 10:29 am by Ilya Somin
 (NA)  Yesterday, the US Court of Appeals for the 5th Circuit ruled against Texas in United States v. [read post]
22 Jun 2011, 2:00 am by Stefanie Levine
On June 20, 2011, the United States Supreme Court granted Mayo's petition for certiorari in Prometheus Laboratories, Inc. v. [read post]
22 Jun 2011, 2:00 am by Stefanie Levine
On June 20, 2011, the United States Supreme Court granted Mayo's petition for certiorari in Prometheus Laboratories, Inc. v. [read post]
30 Nov 2021, 4:53 pm by Nicholas Bagley
Don Verrilli, a former solicitor general of the United States, argued the case for the hospitals. [read post]
9 Mar 2016, 1:34 pm by Lisa Baird and Gillian Clow
The parties’ March 8, 2016 proposed order of settlement includes the following provisions: Defendants agree to be bound by the Court’s conclusion that Amarin may engage in truthful and non-misleading speech promoting the off-label use of Vascepa and, under United States v. [read post]
2 Jun 2014, 5:21 am
  Before he went to trial, Roden “moved to suppress” certain evidence, claiming it was  “obtained in violation of article I, section 7 of the Washington State Constitution, the [state] privacy act, and the 4th Amendment to the United States Constitution. [read post]